Today, Paxman publishes the January issue of its newsletter aimed at shareholders, investors and other interested parties.

This issue highlights the recently published news that the AMA has decided to issue two separate CPT® Category III codes for mechanical scalp cooling. The issuance of these codes is of great importance for Paxman's reimbursement and business strategies in the United States, and it is expected to facilitate further expansion and improved patient access to Paxman scalp cooling.

The newsletter also includes information on completed and planned upgrades and new installations in the UK, as well as that Paxman has received several international orders with installation in Q1 2021. These upcoming international installations includes two PSCS1 systems to the prestigious American Hospital of Paris in France and six additional PSCS2 systems to Brazil.

To read the newsletter and subscribe for upcoming issues, follow this link:

http://bit.ly/paxjan21en

PAXMAN’s investor newsletter is published monthly as a part of the company’s effort to strengthen its market communication together with the IR communication agency Honeybadger. Every published issue of the newsletter is available on PAXMANs website for investors, www.paxman.se. The company encourages feedback and requests on topics for upcoming issues of the newsletter.

Contacts

Richard Paxman, CEO
Tel: +44 7968 020641
Email: richard@paxmanscalpcooling.com
www.paxman.se

About Us

The Paxman Scalp Cooling System has been developed by the Paxman family to reduce hair loss in breast cancer patients undergoing chemotherapy. The concept behind the system came when the mother of four, Sue Paxman, experienced first-hand the trauma of chemotherapy-induced hair loss. With close to 3,500 systems delivered in to hospitals, clinics and treatment centres around the world, PAXMAN is the leading supplier of Scalp Cooling technology. PAXMAN’s scalp-cooling cap is made from lightweight, biocompatible silicone that is soft and flexible, providing a snug yet comfortable fit during treatment. PAXMAN AB (publ) has its headquarters in Karlshamn (Sweden), with subsidiaries in Huddersfield (UK) and Houston, Texas (US).

The PAXMAN share is listed on Nasdaq First North Growth Market. FNCA Sweden AB is the company’s Certified Adviser and can be contacted via info@fnca.se and +46 (0)8 528 003 99.

Attachments

Paxman publishes newsletter on that American Medical Association (AMA) issues CPT® Category III codes for mechanical scalp cooling

© Modular Finance, source Nordic Press Releases